(1 - 7 from 9
)
Cleveland BioLabs Announces Start of Advanced Cancer Trial for ...
www.globenewswire.com
"We are delighted to begin this first study with CBLB502 in cancer patients," stated Yakov Kogan, Ph.D., MBA, interim Chief Executive Officer of Cleveland BioLabs. "This trial is an important step in the development of a product ...
Cleveland BioLabs Announces Science Publication on Molecular ...
www.globenewswire.com
Yakov Kogan, PhD, interim Chief Executive Officer of Cleveland BioLabs, commented: "Selection of this work for publication in this highly prestigious journal indicates the significance of the findings, the complexity of the ...
CBLI Breaking News | Corporate Profile Media
www.corporateprofile.com
Yakov Kogan, Ph.D., MBA, Chief Operating Officer of Cleveland BioLabs, stated, “We are pleased to see the patent portfolio protecting our compounds and technology continue to expand in the US and around the world.
Cleveland BioLabs Gets European Patent For Radiation Protection ...
nuclearstreet.com
Yakov Kogan, Ph.D., MBA, Chief Operating Officer of Cleveland BioLabs noted, “The continued extension of our patent coverage for CBLB502 in key geographies around the world is a testament to its completely unique ...
sorted by relevance / date